Inotiv Share Price (NASDAQ: NOTV)

$1.69

▲

0.01

(0.6%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Inotiv Stock chart to analyse performance

Inotiv stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$1.67
Today's High:$1.71
$1.69
1.18%
Downside
Day's Volatility :2.34%
Upside
1.17%
52 Weeks Low:$1.15
52 Weeks High:$6.48
$1.69
31.95%
Downside
52 Weeks Volatility :82.25%
Upside
73.92%

Inotiv Stock Returns

Period	Inotiv Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-37.64%	3.6%	0.0%
6 Months	-37.41%	-7.7%	0.0%
1 Year	15.75%	-12.6%	0.0%
3 Years	-91.52%	9.5%	-4.7%

Inotiv Inc Key Stats

Check Inotiv key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.68
Open	$1.7
Today's High	$1.71
Today's Low	$1.67
Market Capitalization	$60.5M
Today's Volume	$172.0K
52 Week High	$6.48
52 Week Low	$1.15
Revenue TTM	$505.3M
EBITDA	$21.0M
Earnings Per Share (EPS)	$-2.62
Profit Margin	-15.63%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.46%

Stock Returns calculator for Inotiv Stock including INR - Dollar returns

The Inotiv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inotiv investment value today

Current value as on today

₹1,21,038

Returns

₹21,038

(+21.04%)

Returns from Inotiv Stock

₹15,753 (+15.75%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inotiv Stock

14%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inotiv Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inotiv Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
4.03%
Balyasny Asset Management LLC
3.70%
Millennium Management LLC
1.03%
Vantage Point Financial LLC
0.98%
Geode Capital Management, LLC
0.96%
Susquehanna International Group, LLP
0.87%

Analyst Recommendation on Inotiv Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Inotiv(by analysts ranked 0 to 5 stars)

Inotiv Share Price Target

What analysts predicted

Upside of 225.44%

Target:

$5.50

Current:

$1.69

Inotiv share price target is $5.50, a slight Upside of 225.44% compared to current price of $1.69 as per analysts' prediction.

Inotiv Stock Insights

Price Movement
In the last 7 days, NOTV stock has moved down by -10.6%
Increasing Revenue
Revenue is up for the last 3 quarters, 119.87M → 130.68M (in $), with an average increase of 4.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -14.86M → -17.57M (in $), with an average decrease of 18.2% per quarter
NOTV vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 21.5%
NOTV vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.1% return, outperforming this stock by 176.4%
Price to Sales
ForNOTV every $1 of sales, investors are willing to pay $0.1, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Inotiv Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$43.6M	↑ 65.55%
Net Income	$-790.0K	↑ 307.22%
Net Profit Margin	-1.81%	↓ 1.07%

	FY20	Y/Y Change
Revenue	$60.5M	↑ 38.64%
Net Income	$-4.7M	↑ 493.04%
Net Profit Margin	-7.75%	↓ 5.94%

	FY21	Y/Y Change
Revenue	$89.6M	↑ 48.18%
Net Income	$10.9M	↓ 332.55%
Net Profit Margin	12.16%	↑ 19.91%

	FY22	Y/Y Change
Revenue	$547.7M	↑ 511.19%
Net Income	$-337.3M	↓ 3195.57%
Net Profit Margin	-61.58%	↓ 73.74%

	FY23	Y/Y Change
Revenue	$572.4M	↑ 4.52%
Net Income	$-105.1M	↓ 68.83%
Net Profit Margin	-18.37%	↑ 43.21%

	FY24	Y/Y Change
Revenue	$490.7M	↓ 14.27%
Net Income	$-108.4M	↑ 3.14%
Net Profit Margin	-22.1%	↓ 3.73%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$119.0M	↓ 12.15%
Net Income	$-48.1M	↑ 212.44%
Net Profit Margin	-40.39%	↓ 29.03%

	Q2 FY24	Q/Q Change
Revenue	$105.8M	↓ 11.13%
Net Income	$-26.1M	↓ 45.74%
Net Profit Margin	-24.66%	↑ 15.73%

	Q3 FY24	Q/Q Change
Revenue	$130.4M	↑ 23.28%
Net Income	$-18.9M	↓ 27.58%
Net Profit Margin	-14.49%	↑ 10.17%

	Q4 FY24	Q/Q Change
Revenue	$119.9M	↓ 8.08%
Net Income	$-27.6M	↑ 46.26%
Net Profit Margin	-23.05%	↓ 8.56%

	Q1 FY25	Q/Q Change
Revenue	$124.3M	↑ 3.71%
Net Income	$-14.9M	↓ 46.2%
Net Profit Margin	-11.96%	↑ 11.09%

	Q2 FY25	Q/Q Change
Revenue	$130.7M	↑ 5.12%
Net Income	$-17.6M	↑ 18.24%
Net Profit Margin	-13.45%	↓ 1.49%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$12.9M	↑ 59.2%

	FY20	Y/Y Change
Profit	$18.2M	↑ 41.14%

	FY21	Y/Y Change
Profit	$30.2M	↑ 65.36%

	FY22	Y/Y Change
Profit	$157.2M	↑ 421.33%

	FY23	Y/Y Change
Profit	$165.4M	↑ 5.24%

	FY24	Y/Y Change
Profit	$111.2M	↓ 32.8%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$12.5M	↓ 34.85%

	Q2 FY24	Q/Q Change
Profit	$21.1M	↑ 68.34%

	Q3 FY24	Q/Q Change
Profit	$29.9M	↑ 42.02%

	Q4 FY24	Q/Q Change
Profit	$25.0M	↓ 16.37%

	Q1 FY25	Q/Q Change
Profit	$29.0M	↑ 15.79%

	Q2 FY25	Q/Q Change
Profit	$19.9M	↓ 31.23%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.8M	↓ 49.04%
Investing Cash Flow	$-8.1M	↑ 0.93%
Financing Cash Flow	$6.2M	↑ 25.96%

	FY20	Y/Y Change
Operating Cash Flow	$1.3M	↓ 27.41%
Investing Cash Flow	$-10.1M	↑ 24.32%
Financing Cash Flow	$9.6M	↑ 55.37%

	FY21	Y/Y Change
Operating Cash Flow	$10.7M	↑ 733.02%
Investing Cash Flow	$-54.1M	↑ 433.61%
Financing Cash Flow	$198.8M	↑ 1962.36%

	FY22	Y/Y Change
Operating Cash Flow	$-5.2M	↓ 148.55%
Investing Cash Flow	$-333.7M	↑ 517.32%
Financing Cash Flow	$203.2M	↑ 2.17%

	FY23	Y/Y Change
Operating Cash Flow	$27.9M	↓ 634.46%
Investing Cash Flow	$-28.8M	↓ 91.38%
Financing Cash Flow	$15.9M	↓ 92.19%

	FY24	Y/Y Change
Operating Cash Flow	$-6.8M	↓ 124.41%
Investing Cash Flow	$-16.8M	↓ 41.46%
Financing Cash Flow	$9.7M	↓ 39.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$16.9M	↓ 358.49%
Investing Cash Flow	$-4.6M	↑ 13.46%
Financing Cash Flow	$-1.2M	↓ 59.84%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-14.8M	↓ 187.52%
Investing Cash Flow	$-3.0M	↓ 35.62%
Financing Cash Flow	$-795.0K	↓ 32.23%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.4M	↓ 83.98%
Investing Cash Flow	$-5.2M	↑ 77.75%
Financing Cash Flow	$14.6M	↓ 1931.95%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-4.5M	↑ 89.59%
Investing Cash Flow	$-4.5M	↓ 15.05%
Financing Cash Flow	$26.1M	↑ 79.38%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-12.8M	↑ 184.97%
Investing Cash Flow	$-5.5M	↑ 22.25%
Financing Cash Flow	$-632.0K	↓ 102.42%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-7.4M	↓ 41.88%
Investing Cash Flow	$-2.5M	↓ 54.03%
Financing Cash Flow	$-3.4M	↑ 439.56%

Inotiv Technicals Summary

Sell

Neutral

Buy

Inotiv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Inotiv Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inotiv Inc	-15.92%	-37.41%	15.75%	-91.52%	-90.04%
Agilent Technologies Inc.	9.48%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.87%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	5.33%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.43%	0.1%	-22.08%	-24.82%	-1.19%
Iqvia Holdings Inc.	2.55%	3.11%	-23.4%	-9.93%	15.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inotiv Inc	NA	NA	NA	-0.86	-0.48	-0.03	NA	4.18
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inotiv Inc	Buy	$60.5M	-90.04%	NA	-15.63%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%

About Inotiv Inc

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Organization	Inotiv
Employees	1977
CEO	Mr. Robert W. Leasure Jr.
Industry	Healthcare

Key Management of Inotiv Inc

Name	Title
Mr. Robert W. Leasure Jr.	President, CEO & Director
Ms. Beth A. Taylor CPA	Senior VP of Finance & CFO
Dr. John E. Sagartz D.V.M., DiplomateACVP, Ph.D.	Chief Strategy Officer & Director
Mr. Brennan Freeman	VP of Finance, Principal Accounting Officer & Corporate Controller
Ms. Andrea Castetter	Senior VP of General Counsel & Corporate Secretary and Chief Compliance Officer
Mr. Jeffrey Arthur Krupp	Chief Human Resources Officer
Mr. John Gregory Beattie DSA	Chief Operating Officer of DSA
Dr. Adrian Hardy Ph.D.	Chief Commercial Officer
Ms. Lizanne Muller	Group President of RMS

Important FAQs about investing in NOTV Stock from India :

What is Inotiv share price today?

Inotiv share price today is $1.69 as on August 30, 2025 at 1:29 am IST at the close of the market. Inotiv share today touched a day high of $1.71 and a low of $1.67.

What is the 52 week high and 52 week low for Inotiv share?

Inotiv share touched a 52 week high of $6.48 and a 52 week low of $1.15. Inotiv stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $1.69, lower by 73.92% versus the 52 week high.

How to invest in Inotiv Stock (NOTV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inotiv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inotiv Shares that will get you 0.8876 shares as per Inotiv share price of $1.69 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inotiv Stock (NOTV) from India?

Indian investors can start investing in Inotiv (NOTV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inotiv stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inotiv share’s latest price of $1.69 as on August 30, 2025 at 1:29 am IST, you will get 5.9172 shares of Inotiv. Learn more about fractional shares .

What are the returns that Inotiv has given to Indian investors in the last 5 years?

Inotiv stock has given -90.04% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?